Clinical observation on treatment of acute gouty arthritis by tongfengkang.
- Author:
Jian-ying MA
1
;
You-zhang LIU
;
Zheng ZHOU
Author Information
- Publication Type:Clinical Trial
- MeSH: Acute Disease; Adolescent; Adult; Aged; Arthritis, Gouty; blood; drug therapy; Drugs, Chinese Herbal; therapeutic use; Female; Humans; Male; Middle Aged; Phytotherapy; Single-Blind Method; Uric Acid; blood
- From: Chinese Journal of Integrated Traditional and Western Medicine 2004;24(6):488-490
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo objectively evaluate the clinical therapeutic effect of tongfengkang (TFK) in treating acute gouty arthritis.
METHODSAdopting randomized single blinded controlled trial, the 40 patients were equally divided into two groups. The tested group was treated with TFK, the control group was treated with indomethacin and allopurinol, the therapeutic course for both groups was 10 days.
RESULTSThe clinical cure rate in the tested group and the control group was 30% and 35% respectively, and the total effective rate 90% and 95% respectively, with no significant difference between the two groups (P > 0.05). The scores of blood uric acid and symptom significantly lowered in both groups after treatment (P < 0.01), but showed no significant difference between them (P > 0.05). Adverse reaction to the treatment was shown in 3 patients in the control group.
CONCLUSIONThe therapeutic effect of TFK is similar to that of indomethacin plus allopurinol but with less adverse reaction, it is an effective and safe remedy for treatment of acute gouty arthritis, and worthy for further studying and developing.
